Table 3.
OW/OB | SO | p-value | |
---|---|---|---|
Triglycerides (mmol/L) |
1.4 ± 0.8 |
1.5 ± 0.6 |
0.2 |
(n = 168) |
(n = 147) |
||
Total cholesterol (mmol/L) |
4.5 ± 0.9 |
4.3 ± 0.8 |
0.03 |
(n = 168) |
(n = 147) |
||
HDL-cholesterol (mmol/L) |
1.1 ± 0.3 |
1.0 ± 0.2 |
<0.001 |
(n = 168) |
(n = 147) |
||
LDL-cholesterol (mmol/L) |
2.7 ± 0.8 |
2.6 ± 0.7 |
0.1 |
(n = 168) |
(n = 147) |
||
Total cholesterol/HDL ratio |
4.3 ± 1.2 |
4.5 ± 1.1 |
0.2 |
(n = 168) |
(n = 147) |
||
ALT (U/L) |
24.9 ± 16.0 |
31.6 ± 17.8 |
0.001 |
(n = 157) |
(n = 145) |
||
Fasting glucose (mmol/L) |
4.9 ± 0.4 |
4.9 ± 0.4 |
0.7 |
(n = 159) |
(n = 138) |
||
Fasting insulin (mU/L) |
18.5 ± 15.8 |
31.3 ± 20.4 |
0.02 |
(n = 154) |
(n = 130) |
||
HOMA-IR |
4.0 ± 3.4 |
6.8 ± 4.6 |
0.03 |
(n = 151) |
(n = 123) |
||
Systolic BP (mmHg) |
108 ± 9 |
115 ± 11 |
0.01 |
(n = 174) |
(n = 150) |
|
|
Diastolic BP (mmHg) | 69 ± 8 |
72 ± 9 |
0.01 |
(n = 174) | (n = 150) |
Data are presented as mean ± standard deviation. HDL-C (high density lipoprotein cholesterol), LDL-C (low density lipoprotein cholesterol), ALT (alanine aminotransferase), HOMA-IR (homeostatic model assessment of insulin resistance).
Note 1: Sample sizes vary variable-to-variable because dataset was incomplete.
Note 2: Group comparisons for fasting glucose, fasting insulin, HOMA-IR, systolic BP and diastolic BP were completed using non-parametric analyses since these variables were not normally distributed.